SEC Form 4 · accession 0001179110-15-010735
Ocata Therapeutics, Inc. · OCAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Zohar Loshitzer
Director
Period of report
Jun 30, 2015
Accepted (ET)
Jul 2, 2015 · 4:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001140098
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 30, 2015 | A | 1,250 | — | A | 19,334 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Issued directly to Reporting Person by Issuer representing Board of Director Compensation.